JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
State Street SPDR S&P Insurance ETF
KIE
$684M
| $2.38M | ﹤0.01% |
60,482
-78,009
| -56% | -$3.25M |
|
3277
AngioDynamics
ANGO
$655M
| $2.38M | ﹤0.01% |
229,698
-123,382
| -35% | -$1.58M |
|
3278
E.W. Scripps
SSP
$320M
| $2.37M | ﹤0.01% |
252,188
+65,201
| +35% | +$821K |
|
3279
Haverty Furniture Companies
HVT
$449M
| $2.37M | ﹤0.01% |
74,128
+23,169
| +45% | +$786K |
|
3280
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
| $2.36M | ﹤0.01% |
26,614
-2,401
| -8% | -$219K |
|
3281
CALL
KLA
KLAC
$266B
| $2.35M | ﹤0.01% |
59,000
+9,000
| +18% | +$355K |
|
3282
Peoples Bancorp
PEBO
$1.49B
| $2.35M | ﹤0.01% |
91,306
-4,511
| -5% | -$130K |
|
3283
ING
ING
$102B
| $2.35M | ﹤0.01% |
197,998
-313,701
| -61% | -$4.15M |
|
|
CLCO
3284
DELISTED
Cool Company
CLCO
| $2.35M | ﹤0.01% |
+195,166
| New | +$2.39M |
|
3285
LegalZoom.com
LZ
$963M
| $2.34M | ﹤0.01% |
249,474
+151,614
| +155% | +$1.28M |
|
|
LOCC
3286
DELISTED
Live Oak Crestview Climate Acquisition Corp.
LOCC
| $2.34M | ﹤0.01% |
231,468
| – | – |
|
3287
Amalgamated Financial
AMAL
$1.53B
| $2.34M | ﹤0.01% |
132,046
-12,401
| -9% | -$273K |
|
3288
CALL
Melco Resorts & Entertainment
MLCO
$2.17B
| $2.34M | ﹤0.01% |
183,500
| – | – |
|
3289
CALL
Teladoc Health
TDOC
$1.24B
| $2.33M | ﹤0.01% |
+90,100
| New | +$2.41M |
|
3290
Capitol Federal Financial
CFFN
$1.08B
| $2.33M | ﹤0.01% |
346,267
-257,714
| -43% | -$2.09M |
|
3291
Invesco S&P 500 Pure Growth ETF
RPG
$2.1B
| $2.33M | ﹤0.01% |
77,045
-845
| -1% | -$25.8K |
|
3292
Aurinia Pharmaceuticals
AUPH
$2.06B
| $2.32M | ﹤0.01% |
211,942
+70,932
| +50% | +$625K |
|
3293
FuelCell Energy
FCEL
$1.79B
| $2.32M | ﹤0.01% |
27,121
+4,429
| +20% | +$436K |
|
3294
Seaboard Corp
SEB
$4.18B
| $2.31M | ﹤0.01% |
613
+185
| +43% | +$716K |
|
3295
New Oriental
EDU
$8.36B
| $2.31M | ﹤0.01% |
59,829
+15,460
| +35% | +$625K |
|
3296
Theravance Biopharma
TBPH
$881M
| $2.31M | ﹤0.01% |
212,527
-1,321
| -0.6% | -$14K |
|
3297
CALL
Thermo Fisher Scientific
TMO
$218B
| $2.31M | ﹤0.01% |
4,000
-62,100
| -94% | -$35M |
|
|
HAYN
3298
DELISTED
Haynes International, Inc.
HAYN
| $2.31M | ﹤0.01% |
46,016
+6,739
| +17% | +$354K |
|
3299
Procept Biorobotics
PRCT
$1.24B
| $2.3M | ﹤0.01% |
81,116
+51,679
| +176% | +$1.82M |
|
3300
AAR Corp
AIR
$5.85B
| $2.3M | ﹤0.01% |
42,091
+7,238
| +21% | +$375K |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.